Track topics on Twitter Track topics that are important to you
The aim of this study is to validate in the context of liver transplantation, the interest of the cccDNA assay technique developed by the team of Professor Zoulim (INSERM U1052) on liver biopsy and correlate this assay cccDNA in hepatitis B virus (HBV) viral load and serum liver through several groups of patients at transplantation (on graft and native liver explant) and after transplantation.
Time Perspective: Prospective
cccDNA assay on liver biopsy
Service d'Hépatologie, Hôpital de la Croix-Rousse
Hospices Civils de Lyon
Published on BioPortfolio: 2015-11-12T19:08:23-0500
Serum HBV DNA is a referent but insufficient marker of therapeutic follow-up in chronic hepatitis B treatment. Intra hepatic cccDNA disappearance reflects HBV eradication in the liver. ...
This study will examine liver tissue to investigate the role of viral infections in fulminant hepatitis, liver failure, and profound bone marrow failure. All patients who are undergoing l...
To validate the use of a RNAseq-based peripheral blood assay in liver transplant recipients when correlated to liver biopsy results.
Fifty patients awaiting liver transplantation and 50 age and gender matched control subjects with normal liver function will be included in the study. The aim of this project is to compare...
INTERLIVER is a prospective observational study of the relationship of the molecular phenotype of 300 liver transplant biopsies to the histologic phenotype and the clinical features and ou...
The combination of two-stage total hepatectomy and partial liver transplantation (LT) for secondary unresectable liver-only malignancies is producing a great quantity of literature. In the first stage...
Liver transplantation (LT) for patients with propionic acidaemia (PA) is an emerging therapeutic option.
Living donor liver transplantation (LDLT) is becoming an established procedure for treating patients with end-stage liver disease; however, small-for-size graft syndrome has been a major obstacle to t...
We read with great interest the article recently published in Liver Transplantation by Ikegami and colleagues (1). This study compared the clinical results of patients with and without portal vein thr...
Renal dysfunction is common in liver transplant (LT) candidates but differentiating between reversible and irreversible renal injury can be difficult. Kidney biopsy might be helpful in differentiating...
Final stage of a liver disease when the liver failure is irreversible and LIVER TRANSPLANTATION is needed.
Conditions in which the LIVER functions fall below the normal ranges. Severe hepatic insufficiency may cause LIVER FAILURE or DEATH. Treatment may include LIVER TRANSPLANTATION.
The transference of a part of or an entire liver from one human or animal to another.
Single or multiple areas of PUS due to bacterial infection within the hepatic parenchyma. It can be caused by a variety of BACTERIA, local or disseminated from infections elsewhere such as in APPENDICITIS; CHOLECYSTITIS; PERITONITIS; and after LIVER TRANSPLANTATION.
Sudden liver failure in the presence of underlying compensated chronic LIVER DISEASE (e.g., LIVER CIRRHOSIS; HEPATITIS; and liver injury and failure) due to a precipitating acute hepatic insult.
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity. This can be a drug or biochemical substance or a cell in an organism or organic sample. ...
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...